A phase 1, randomized, double-blind, placebo-controlled, parallel-group, single dose study to assess the tolerability, safety, and pharmacokinetics of alefacept in Caucasian and Japanese healthy volunteers

Trial Profile

A phase 1, randomized, double-blind, placebo-controlled, parallel-group, single dose study to assess the tolerability, safety, and pharmacokinetics of alefacept in Caucasian and Japanese healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2013

At a glance

  • Drugs Alefacept (Primary) ; Alefacept (Primary)
  • Indications Psoriasis; Transplant rejection
  • Focus Pharmacokinetics
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 19 Aug 2008 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
    • 19 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 28 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top